The Braves face challenges in their Trade Deadline plans due to injuries to key pitching prospects Spencer Strider and Hurston Waldrep. Strider’s ongoing elbow issues may hinder his role as a starter, and Waldrep is dealing with similar concerns. While the Braves have strong assets in their farm system, including top prospects like Cam Caminiti and Eric Hartman, trading any of these players could impact their long-term pitching depth. Teams may be interested in Strider, but Atlanta could be compelled to absorb some of his $66 million contract if they choose to deal him.

By the Numbers
  • Spencer Strider has $66 million remaining on his contract over the next three years.
  • Strider and Waldrep have both sustained elbow injuries that could limit their availability this season.
State of Play
  • Strider has not pitched since June 12 and remains without a clear prognosis.
  • Waldrep was sidelined again after a brief return due to elbow discomfort.
  • Spencer Schwellenbach is reaccelerating his rehab after a year off due to a fractured elbow.
What's Next

The Braves may consider trading Strider if medical evaluations allow, but they need to ensure they maintain future rotation strength. Atlanta's approach to potential trades will likely hinge on the medical updates for their injured pitchers. This could result in strategic choices on which prospects to retain or move, depending on the outlook for Strider and Waldrep.

Bottom Line

The Braves face critical decisions at the Trade Deadline, balancing immediate needs against long-term roster depth concerns. With talented prospects available, Atlanta must proceed cautiously, particularly with pitching assets impacted by injuries. Their future success may depend on navigating this complex landscape effectively.